Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Manufacturing

    Engineering Change Order / Notice(ECO / ECN)

    In one line
    Documents that authorize and communicate changes to released designs, BOMs, or manufacturing processes.
    Definition
    ECO/ECN processes are the practical mechanism behind the 21 CFR 820.30(i) and ISO 13485 §7.3.9 design change requirements. They link the change request to impact analysis, approvals, training, and effectivity. A typical change process covers the request, impact assessment on design, risk, validation and regulatory status, approvals by a change board, and an effective date. Regulatory review decides whether a change needs a new 510(k), a PMA supplement or notified body notification. FDA guidance on deciding when to submit a 510(k) for a change is a common reference.
    Why it matters
    PLM systems automate ECO routing; weak effectivity tracking leads to mixed-revision inventory and field issues.
    Common pitfalls
    • •Failing to assess the full impact of a change across all relevant product documentation, manufacturing processes, and supplier agreements is a common pitfall.
    • •Implementing a change without adequate verification or validation can lead to product non-conformities and patient safety issues.
    • •Not involving all necessary stakeholders, such as regulatory, quality, R&D, and manufacturing teams, in the ECO/ECN process can result in overlooked requirements or implementation challenges.
    • •Poor control over effectivity dates can result in mixed inventory, making it difficult to trace which product versions are in the field and comply with specific change implementations.
    • •Treating minor changes with the same rigorous process as major ones, or conversely, not giving sufficient attention to cumulative minor changes, can bottleneck operations or introduce uncontrolled risk.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.